This article is educational and reflects evidence and access as of July 15, 2026. A cat with open-mouth breathing, marked breathing effort, collapse, seizures, inability to stand, rapidly enlarging abdomen, severe weakness, pale or blue gums, or inability to eat or drink needs urgent or emergency veterinary care.

What Is FIP in Cats? Symptoms, Diagnosis, Treatment, and Outlook

Quick Answer

Feline infectious peritonitis (FIP) is a serious inflammatory disease that develops in a minority of cats infected with feline coronavirus (FCoV). Common intestinal FCoV infection is widespread, especially where many cats share litter areas, and is often asymptomatic or causes mild gastrointestinal signs. FIP occurs when virus–host interactions permit systemic infection of monocytes and macrophages and a harmful immune response. A positive “coronavirus” result does not mean a cat has FIP or will develop it [1][2].

FIP can cause persistent or waxing fever, appetite loss, weight loss or failure to grow, lethargy, abdominal or chest fluid, jaundice, enlarged lymph nodes or organs, eye inflammation, imbalance, behavior change, tremors, weakness, or seizures. The traditional labels wet FIP (effusive) and dry FIP (non-effusive) describe ends of a spectrum. Cats can have mixed disease or change presentation, and ocular or neurologic involvement can occur with or without visible body-cavity fluid [1][3].

There is no single routine blood test that diagnoses every case. Veterinarians combine age and history, examination, complete blood count and chemistry, imaging, and tests on the most informative available sample—often abdominal or chest effusion, affected tissue, eye fluid, or cerebrospinal fluid [1][2][4]. A serum FCoV antibody test shows exposure, not FIP. A fecal coronavirus PCR measures intestinal shedding and should not be used to diagnose FIP [1][2]. Detection of viral antigen within macrophages in characteristic tissue lesions by immunohistochemistry remains the reference confirmation, but biopsy may be invasive and a well-supported clinical diagnosis is sometimes necessary [1][2].

FIP is no longer automatically fatal. Antivirals—particularly oral GS-441524, and in some settings remdesivir—have transformed the outlook. Updated 2026 ABCD guidance describes FIP as treatable and frequently curable, with treatment success often above 90% in published GS-441524 studies, while emphasizing selection, access, formulation, disease severity, early deaths, relapse, and study-design limitations [5]. That population result is not a guarantee for an individual cat.

Treatment must be prescribed and monitored by a veterinarian. Drug availability and regulatory status vary by country and can change. In the United States, FDA announced in May 2024 that it did not intend to enforce certain new-animal-drug approval requirements for patient-specific GS-441524 compounded under specified GFI #256 conditions; FDA also stressed that such compounded drugs remain unapproved and are not equivalent to an FDA-approved product [6]. Do not buy an unidentified product, calculate a dose from social media, or delay diagnosis while sourcing medication privately.

Feline Coronavirus Is Not the Same as FIP

Feline coronavirus usually refers to alphacoronaviruses adapted to cats. FCoV spreads mainly by the fecal–oral route. Shared litter trays, contaminated paws and objects, and dense multi-cat housing facilitate transmission. Many infected cats shed virus in feces for a time; some shed intermittently or persistently. Most never develop FIP [1][2].

FIP is the disease syndrome produced when FCoV gains the ability to replicate effectively in monocytes/macrophages and the individual cat's immune response drives systemic vasculitis and pyogranulomatous inflammation. Viral genetic changes occur within the infected cat, but no single commercially tested mutation cleanly separates every harmless intestinal infection from every FIP case. The cat's genetics, age, immune state, viral factors, stress, and environment interact [1][2].

This distinction prevents several harmful conclusions:

• An FCoV-positive healthy cat does not have a death sentence.
• A high antibody titer is not proof of FIP.
• A fecal PCR-positive cat is shedding FCoV but may be healthy.
• A fecal PCR-negative cat can still have FIP.
• An FIP diagnosis in one cat does not mean every housemate will develop FIP.
• The clinically ill cat is not usually spreading a unique, reliably identifiable “FIP virus” in ordinary contact.

FCoV itself can circulate among cats, so litter hygiene and population management still matter. Isolation decisions should balance transmission reduction with welfare and the fact that housemates may already have been exposed.

Which Cats Develop FIP?

FIP can occur at any age. It is overrepresented in young cats, particularly those under two years, and in multi-cat environments such as shelters, rescues, and breeding households [1][2]. Older cats can develop it, too. Recent treatment cohorts often contain many young and purebred cats, but referral and testing patterns affect those proportions [7].

Risk associations are not destiny. Purebred status, recent rehoming, surgery, vaccination, another illness, crowding, and stressful events may correlate with timing or population risk, but a temporal event does not prove it caused FIP. Blaming a routine vaccine, a shelter, a breeder, or an owner from timing alone is scientifically and emotionally harmful.

Household stress reduction, adequate resources, small stable groups, litter hygiene, and avoiding crowding are reasonable. No supplement or diet has been shown to guarantee prevention after FCoV exposure. Genetic selection for a single laboratory measure has not solved FIP risk and may narrow diversity.

FIP Symptoms in Cats

Early FIP signs are often nonspecific. They overlap with infection, cancer, liver disease, inflammatory bowel disease, heart disease, toxoplasmosis, immune-mediated disease, and many other conditions.

Common early concerns include:

• persistent, recurrent, or treatment-unresponsive fever;
• reduced appetite;
• lethargy;
• weight loss;
• failure of a kitten to gain expected weight;
• poor coat or muscle loss;
• pale mucous membranes;
• jaundice; and
• enlarged abdominal lymph nodes or organs.

No single item establishes FIP. A kitten with diarrhea and a positive fecal coronavirus PCR may simply have enteric FCoV or another intestinal problem. A senior cat with weight loss needs a broad diagnostic assessment.

Effusive or “Wet” FIP

Inflammation of blood vessels and serosal surfaces can lead to protein-rich fluid in the abdomen, chest, or less commonly around the heart.

Abdominal effusion may cause:

• a progressively enlarged or pear-shaped abdomen;
• weight loss over the spine despite abdominal size;
• reduced appetite;
• discomfort or reduced activity; and
• sometimes breathing restriction when fluid volume is large.

Chest fluid may cause fast or labored breathing, shallow breaths, inability to settle, neck extension, or open-mouth breathing. A cat in respiratory distress should receive oxygen and stabilization before stressful handling or extensive diagnostics. Open-mouth breathing in a resting cat is an emergency.

Fluid appearance can be straw-yellow and viscous, but appearance is not diagnostic. Heart failure, cancer, bacterial infection, bleeding, low blood protein, liver disease, and chylous effusion are among alternatives. Sampling and analysis matter.

Non-Effusive or “Dry” FIP

Non-effusive FIP produces inflammatory lesions in organs without a large easily sampled body-cavity effusion. Signs depend on location:

• kidney involvement may produce enlargement or irregularity;
• liver disease may cause jaundice or enzyme changes;
• intestinal or lymph-node lesions may cause vomiting, diarrhea, a mass, or weight loss;
• lung involvement can affect breathing;
• skin lesions are uncommon but possible; and
• systemic inflammation can cause fever and anemia.

“Dry” does not mean mild. It can be diagnostically harder because there is no large fluid sample. Ultrasound-guided fine-needle aspirates or biopsy of accessible lesions may be considered, with risks and yield discussed.

Ocular FIP

FIP can inflame structures inside the eye. Signs include cloudiness, redness, squinting, light sensitivity, unequal pupils, color change of the iris, blood or inflammatory material in the eye, retinal change, or vision loss. Ocular disease can be unilateral or bilateral and can coexist with systemic or neurologic FIP [1][3].

A red or cloudy eye is urgent because glaucoma, uveitis from other causes, trauma, lens disease, and infection can threaten vision. Do not use leftover steroid or antibiotic drops before examination; some medications worsen corneal ulcers or infection.

Neurologic FIP

Neurologic signs may include:

• unsteady gait or falling;
• weakness or inability to jump;
• tremors;
• head tilt, circling, or abnormal eye movements;
• behavior or mentation change;
• seizures;
• difficulty swallowing;
• abnormal spinal pain or sensitivity;
• urinary or fecal dysfunction; and
• progressive paralysis.

Neurologic disease often requires different diagnostic sampling, imaging, treatment intensity, and monitoring. The blood–brain and blood–eye barriers affect drug exposure. A 2025 case report of neurologic re-emergence after a short initial course illustrates that apparent early recovery does not eliminate relapse risk and cannot define a universal protocol [8].

Is FIP Contagious?

FCoV is contagious among cats; the clinical syndrome FIP is not generally treated as a directly transmitted condition in the way panleukopenia is. Cats usually acquire common enteric FCoV from other cats, and disease-associated viral changes arise within individuals [1][2].

When one cat develops FIP, housemates have often already shared FCoV exposure. Do not abandon, euthanize, or permanently isolate healthy housemates based only on that diagnosis. Monitor weight, appetite, energy, temperature when instructed, and clinical signs. Discuss higher-risk kittens or immunocompromised cats with the veterinarian.

Improve litter hygiene:

• provide enough boxes distributed across the home;
• scoop frequently;
• keep litter away from food and water;
• clean contaminated surfaces appropriately;
• reduce tracked litter and fecal contamination;
• avoid overcrowding; and
• maintain stable social groups.

Fecal PCR can be useful in specialized population-management programs, but one negative result does not prove permanent non-shedding. Serial testing and context are required. It is not a screening test that predicts which healthy cat will develop FIP [1].

FCoV is not SARS-CoV-2. Feline coronavirus biology and FIP treatment should not be translated from human COVID-19 advice. FIP is not considered a routine zoonotic risk to people.

How Veterinarians Diagnose FIP

Diagnosis is a process of accumulating and weighing evidence. The ideal test and sample depend on whether effusion, a focal lesion, eye disease, or neurologic disease is present.

History and Examination

Age, origin, multi-cat exposure, recent stressors, duration, fever pattern, weight trajectory, and treatment response shape the pretest probability. Examination assesses hydration, temperature, mucous membranes, lymph nodes, abdominal organs or fluid, heart and lungs, eyes, and neurologic function.

Signalment can support suspicion but must not replace testing. Young shelter cats also develop congenital disease, parasites, bacterial infection, panleukopenia, toxoplasmosis, lymphoma, and other treatable conditions.

Routine Blood and Urine Tests

Possible findings include nonregenerative anemia, lymphopenia, neutrophilia, high globulins, low albumin, a low albumin-to-globulin ratio, elevated bilirubin, liver changes, and inflammatory markers. None is specific. A normal result does not exclude every FIP presentation [1][2].

Albumin-to-globulin ratio helps shift probability when interpreted with the rest of the case. It is not a standalone diagnostic cutoff. Different laboratories, dehydration, liver function, protein loss, chronic infection, and cancer alter proteins.

Urinalysis, FeLV/FIV testing, parasite testing, cultures, and other infectious-disease tests may identify alternatives or concurrent illness. One abnormality should not end the investigation prematurely.

Imaging

Radiographs may show chest or abdominal fluid and changes in organ silhouettes. Ultrasound can detect small effusions, enlarged lymph nodes, altered kidneys, liver or intestines, and guide sampling. Echocardiography may be needed when heart disease could explain effusion. MRI is often used for neurologic localization when available.

Imaging can locate disease but usually cannot label it FIP by appearance alone. “FIP-like kidneys” or an abdominal mass still has differentials.

Effusion Analysis

When fluid is safely accessible, it is often the highest-yield sample. The laboratory may assess protein, cell count, cytology, biochemical markers, bacterial culture when indicated, Rivalta test, FCoV RT-PCR, or viral-antigen immunostaining in macrophages [1][2][4].

The Rivalta test is a low-cost test of effusion characteristics. A negative result can make FIP less likely in an appropriate population; a positive result is not specific and occurs with other inflammatory or neoplastic effusions. It should never stand alone.

FCoV PCR on effusion is more informative than fecal or often blood testing in a compatible case, but detection of RNA is not perfectly specific. Viral load, sample, laboratory method, and clinical context matter [1][2].

Antibody Testing

There is no “FIP antibody” test. Serum assays detect antibodies against FCoV. Healthy exposed cats can have high titers, and some cats with confirmed FIP can test negative. The 2022 AAFP/EveryCat guidelines do not recommend antibody testing in serum, plasma, or other fluids as a standalone FIP diagnostic method [2].

A positive result means exposure and immune response. It does not prove mutation, systemic inflammatory disease, contagiousness at that moment, prognosis, or need for antiviral treatment.

PCR Testing

RT-PCR detects viral RNA. Interpretation depends on sample:

• Feces: useful for shedding studies, not FIP diagnosis.
• Blood: low or variable yield; viremia can occur without FIP.
• Effusion: often more useful in a compatible case.
• Affected tissue or fine-needle aspirate: can support diagnosis, but systemic FCoV can occur without FIP.
• Cerebrospinal or eye fluid: may contribute in the right presentation, with sensitivity and collection limitations.

PCR assays marketed around spike-gene mutations do not perfectly distinguish FIP-associated virus from systemic FCoV. A mutation result should not overrule the whole case [1][2].

Cytology, Histopathology, and Immunostaining

Cytology can reveal inflammatory patterns, macrophages, lymphoma, bacteria, or another process. Immunocytochemistry attempts to demonstrate FCoV antigen within macrophages in fluid or aspirates. A positive result in a strongly compatible case can be powerful; sensitivity and false results vary by sample and technique [1][2][4].

Histopathology showing characteristic lesions with FCoV antigen in lesion macrophages by immunohistochemistry is the diagnostic reference standard [1][2]. Obtaining tissue may require anesthesia or surgery and may be unsafe in a critically ill cat. Clinicians balance certainty with procedural risk and the urgency of treatment.

Response to Antiviral Treatment

Rapid improvement during appropriate antiviral care can support a presumptive diagnosis, but response alone is not proof. Fever and appetite can change with fluids, analgesia, anti-inflammatory care, drainage, antibiotics, or time. Other diseases may coexist. A cat that fails to improve may have an incorrect diagnosis, irreversible injury, inadequate drug exposure, severe disease, another condition, or early complications—not simply “resistant FIP.”

FIP Treatment in 2026

Treatment has changed rapidly. Current professional guidance should be checked at the time of care.

GS-441524

GS-441524 is a nucleoside analogue and the parent nucleoside related to remdesivir. It interferes with viral RNA replication. It is the most extensively studied antiviral for FIP, and updated ABCD guidance reports treatment success often exceeding 90% across selected studies [5].

That headline requires context. Studies differ in diagnostic certainty, formulation, dose, route, disease form, follow-up, inclusion, and definition of success. Cats dying very early may be excluded from some conditional analyses. Neurologic and ocular disease can require different exposure. Real-world compounded product quality varies. A published success rate is not a warranty.

Oral pharmaceutical or professionally compounded formulations have made treatment easier in many regions. Injectable products can be painful and are no longer the default everywhere. The veterinarian chooses route and formulation based on legal access, swallowing, vomiting, absorption, disease severity, product quality, and evidence.

Remdesivir

Remdesivir is a related nucleotide prodrug. It has been used intravenously or subcutaneously, sometimes at the start of treatment in cats too sick to swallow or absorb oral medication, followed by oral GS-441524 [5][9]. A prospective study of 28 cats treated with remdesivir with or without transition to oral GS-441524 reported 24 survivors at six months; three deaths occurred within 48 hours [9]. This demonstrates both meaningful benefit and the danger of severe presentation.

A 2026 randomized double-blind trial in only 20 cats with non-effusive FIP compared oral remdesivir with oral GS-441524 for 84 days [10]. At week 16, 9 of 10 remdesivir-treated and 7 of 10 GS-441524-treated cats were alive in clinical remission; the study met its prespecified noninferiority criterion, but its confidence interval was wide and possible late relapses were reported in both groups [10]. It does not establish that one product is universally superior.

Other Antivirals

Molnupiravir and its active metabolite, protease inhibitors such as GC376, and combinations have been investigated or used where first-line drugs fail or are unavailable [5]. Evidence and safety are not equivalent across drugs. Molnupiravir raises mutagenicity, reproductive, handling, and resistance considerations; it is not a casual substitute. Nirmatrelvir and other agents remain specialist territory.

Owners should not combine antivirals, switch products, or escalate doses based on online groups. Drug interactions, formulation concentration, neurologic penetration, organ function, and resistance selection matter.

Treatment Duration

Eighty-four days became a common historical course and remains widely used. New evidence and guidelines discuss shorter 42-day courses for carefully selected cats with appropriate response and monitoring [5]. “Six weeks now works” is an unsafe generalization. Disease form, initial severity, diagnostic confidence, formulation, weight gain, laboratory normalization, adherence, and relapse risk influence decisions.

Do not stop when the cat looks better. Fever and appetite often improve quickly, while inflammatory lesions and laboratory abnormalities take longer. The prescriber decides when criteria for stopping are met.

Supportive Care

Antivirals address viral replication; the cat may still need stabilization and supportive treatment:

• oxygen and cautious drainage for respiratory compromise;
• fluid therapy tailored to hydration and effusions;
• nutritional support and anti-nausea care;
• analgesia;
• treatment of anemia or coagulopathy;
• eye-specific therapy;
• seizure control and neurologic nursing;
• management of concurrent infections or disease; and
• low-stress, warm, clean hospitalization.

Repeated large-volume abdominal drainage is not automatically beneficial; fluid may reaccumulate and protein loss or instability matters. Chest effusion causing breathing difficulty often requires therapeutic drainage. These decisions belong to the treating team.

Steroids and immune-modulating drugs are not antiviral substitutes. They may have selected indications for severe inflammation, ocular disease, neurologic disease, or concurrent conditions, but routine use, dose, and taper require veterinary judgment [5].

Legal Access and Product Quality

Rules differ by country and change quickly. Some countries have authorized veterinary formulations, others permit extralabel human medicines, and others use pharmacy compounding or special-access pathways.

In the United States, FDA's May 10, 2024 statement says it did not intend to enforce new animal drug approval requirements for GS-441524 compounded for a specific cat under GFI #256 conditions [6]. FDA explicitly noted that drugs compounded from bulk substance are unapproved. Patient-specific prescription, pharmacy and state rules, and professional oversight matter. “Available” should not be simplified to “FDA approved.”

Unregulated products may contain the wrong concentration, contamination, inconsistent ingredients, or no active drug. A label and testimonials do not establish quality. Private sourcing also fragments records and may delay diagnosis, monitoring, or adverse-event reporting.

Ask the veterinarian:

• what legal pathway applies here;
• who compounds or supplies the product;
• how concentration and quality are controlled;
• how refills will be timed;
• what to do after vomiting or a missed dose;
• what monitoring is required;
• how weight changes affect the prescription; and
• who provides urgent coverage.

This article intentionally does not provide a dose. Published doses vary by molecule, formulation, route, disease compartment, and evolving guideline. Copying a number without those variables can undertreat, overdose, or select resistance.

Monitoring During Treatment

Monitoring confirms response, detects toxicity or another diagnosis, and keeps exposure appropriate as a thin kitten gains weight.

Track at home:

• body weight on the same reliable scale;
• appetite and measured intake when possible;
• energy and engagement;
• resting breathing rate and effort;
• abdominal size without forceful palpation;
• vomiting and stool;
• thirst and urination;
• eye appearance and vision behavior;
• gait, tremor, seizures, and behavior;
• every administered dose and any vomiting; and
• other medications.

Veterinary rechecks may include examination, weight-based prescription review, complete blood count, chemistry, bilirubin, albumin, globulin, albumin-to-globulin ratio, and inflammatory markers. Imaging or fluid assessment may be repeated when it will change care [5]. No one value alone declares cure.

Improvement is often seen within days, especially fever and appetite, but some cats recover more slowly. Lack of meaningful response should trigger reassessment of diagnosis, adherence, formulation, absorption, dosing calculation, neurologic or ocular involvement, and concurrent disease.

Adverse Effects

Reported adverse effects depend on drug and route. Injection can be painful and cause skin injury. Oral medication can cause gastrointestinal signs, and laboratory abnormalities may occur. Compounded formulations add variability. New signs should be reported, not managed by silent dose changes.

Keep medication away from children and other animals. Follow pharmacy handling instructions, especially for agents with human reproductive or genotoxic concerns. Do not crush, split, or reformulate unless the pharmacist confirms it is appropriate.

Relapse, Re-emergence, and Reinfection

Relapse means FIP signs return after apparent response or treatment completion. It may involve the same compartment or emerge as ocular/neurologic disease. Causes can include inadequate exposure, poor absorption, missed medication, early discontinuation, disease behind protected barriers, or antiviral resistance, although proving cause is difficult [5][8][10].

New fever, weight loss, effusion, eye change, imbalance, tremor, or seizure during or after treatment deserves prompt evaluation. Do not restart leftover medication at an old dose. Weight and disease pattern may have changed, and samples collected before restarting may be diagnostically valuable.

Not every post-treatment illness is relapse. Cats can develop unrelated infection, gastrointestinal disease, toxoplasmosis, lymphoma, congenital disease, or adverse drug effects. Confirmation prevents months of inappropriate therapy.

Reinfection with enteric FCoV remains possible because treatment of FIP does not sterilize the environment or guarantee durable protection from every FCoV. Whether reinfection leads to another FIP episode depends on complex factors and appears uncommon relative to successful remission.

Prognosis

Without effective antiviral treatment, progressive clinical FIP has historically been fatal. With current antivirals, many cats achieve sustained remission and return to normal quality of life [5][7][9][10]. The word “cure” is increasingly reasonable after durable remission, but no exact date or test proves zero future risk.

Prognosis varies with:

• severity at presentation;
• respiratory or circulatory compromise;
• neurologic involvement;
• ability to eat and absorb medication;
• organ injury;
• diagnostic accuracy;
• antiviral quality and access;
• promptness and continuity of care;
• response during the first days and weeks;
• concurrent disease; and
• follow-up duration.

Early deaths remain a major limitation even in successful studies. In the 28-cat remdesivir study, three cats died within 48 hours [9]. Families should hear both hope and urgency.

Euthanasia can still be a humane decision when suffering cannot be stabilized, severe irreversible injury exists, a diagnosis remains incompatible with effective care, or treatment is inaccessible despite efforts. That is not an owner's moral failure. Ask the team to explain comfort, realistic options, costs, monitoring, and contingency plans.

Prevention and Multi-Cat Management

There is no prevention method that guarantees an FCoV-exposed cat will avoid FIP.

Practical population measures include:

• avoiding overcrowding;
• keeping stable, compatible groups;
• separating litter, food, and water areas;
• providing enough large, clean litter boxes;
• scooping frequently;
• reducing fecal tracking;
• cleaning and drying surfaces;
• quarantining and health-screening newcomers appropriately;
• maintaining nutrition, vaccination, parasite control, and preventive care; and
• reducing avoidable stress without socially isolating cats.

The new-pet quarantine guide explains how to introduce infection control without assuming one test makes a newcomer risk-free. The preventive care guide for cats covers routine protection that supports health but does not specifically guarantee FIP prevention.

A commercial intranasal FIP vaccine exists in some regions, but evidence and timing limitations mean major guidelines do not treat it as a routine broadly effective solution [1][2]. Vaccinating an already FCoV-exposed cat is unlikely to solve risk. Follow current local feline vaccination guidance rather than a product claim alone.

Common Myths

“A Positive Coronavirus Test Means FIP”

No. Antibody tests indicate exposure; fecal PCR indicates shedding. FIP diagnosis requires clinical and sample-specific evidence [1][2].

“A Negative Coronavirus Test Rules Out FIP”

No. Cats with confirmed FIP can have negative antibody or PCR results depending on sample, assay, viral load, and disease form.

“Wet and Dry FIP Are Two Different Viruses”

They are overlapping presentations of one disease spectrum. Cats can have mixed effusive, organ, ocular, and neurologic features.

“FIP Is Still Always Fatal”

No. Effective antivirals have transformed outcomes, though rapid diagnosis, reliable drug access, monitoring, and early severity still matter [5].

“A 90% Success Rate Guarantees My Cat Will Recover”

No. Study selection, formulation, presentation, and follow-up vary. Population outcomes inform hope; they do not predict an individual with certainty.

“Any GS-441524 Product Is Equivalent”

No. Concentration, purity, formulation, storage, and regulatory oversight differ. Use a veterinarian-prescribed pathway.

“If the Cat Looks Normal After a Week, Treatment Can Stop”

No. Visible improvement precedes full control. Stopping criteria and duration are clinician decisions.

“Housemates Must Be Rehomed”

Usually not. They may already share ordinary FCoV exposure, while FIP itself is not generally directly transmitted as a distinct syndrome. Improve management and monitor.

“The Cat Got FIP From a Vaccine or Spay”

Stressful events can precede illness, but timing does not establish causation. FCoV infection and host–virus interactions underlie FIP.

“Supplements Cure FIP Naturally”

No supplement has evidence comparable to effective antivirals. Supportive nutrition is valuable, but delaying antiviral care can be fatal.

What to Do If FIP Is Suspected

1. Assess urgency. Breathing difficulty, collapse, seizures, inability to stand, or severe weakness requires emergency care.
2. Collect records. Bring weights, temperature history if professionally obtained, lab results, imaging, adoption history, medications, and videos.
3. Ask for a differential-based plan. Clarify what supports FIP, what argues against it, and which alternatives remain.
4. Sample the best site safely. Effusion or an accessible lesion is often more useful than broad blood PCR.
5. Discuss treatment while testing proceeds. In a high-probability deteriorating case, waiting for perfect certainty may be dangerous, but empiric therapy should still be supervised and reassessed.
6. Confirm legal access. Use a patient-specific veterinary prescription and reliable pharmacy or authorized source.
7. Plan monitoring and finances. Include rechecks, laboratory work, emergency care, drug refills, and contingencies.
8. Protect welfare. Use feline-friendly handling, nutrition, pain relief, clean litter, warmth, and social support.

The emergency-vet guide can help triage severe breathing, neurologic, or collapse signs, but suspected FIP should not wait for every textbook feature.

Frequently Asked Questions

What causes FIP in cats?

FIP develops after feline coronavirus infection when virus–host interactions permit systemic macrophage infection and damaging inflammation. Most FCoV-infected cats do not develop FIP.

Is FIP curable?

Many cats now achieve sustained remission with veterinarian-managed antiviral treatment, particularly GS-441524. Updated guidance describes FIP as frequently curable, but severe early disease, relapse, access, and study limitations prevent guarantees [5].

How is FIP diagnosed?

Veterinarians combine history, examination, blood tests, imaging, and analysis of effusion or affected tissue. Viral antigen in lesion macrophages by immunohistochemistry is reference confirmation, but a composite presumptive diagnosis is often used when invasive biopsy is unsafe.

Does a positive feline coronavirus test mean FIP?

No. Antibody positivity indicates exposure and fecal PCR indicates shedding. Both can occur in healthy cats [1][2].

What are the first signs of FIP?

Early signs often include reduced appetite, lethargy, weight loss or failure to grow, and persistent or recurring fever. These signs are nonspecific and need veterinary investigation.

What is the difference between wet and dry FIP?

Wet FIP has appreciable body-cavity effusion; dry FIP has organ-centered inflammatory lesions without large effusion. They overlap, and ocular or neurologic disease can occur with either.

Is FIP contagious to other cats?

Common FCoV is contagious, mainly through fecal–oral exposure. FIP is not generally considered directly contagious as a distinct disease form. Housemates may already have FCoV exposure but are not destined to develop FIP.

Is FIP contagious to humans or dogs?

Feline coronavirus is adapted to cats and FIP is not considered a routine zoonotic disease. It is distinct from SARS-CoV-2. Dogs do not ordinarily acquire feline FIP through household contact.

How long is FIP treatment?

An 84-day course has been common, while current guidance discusses 42-day protocols for selected, well-monitored cases [5]. The veterinarian chooses duration based on presentation, drug, response, and monitoring; owners should not shorten treatment themselves.

Can FIP come back after treatment?

Yes, relapse or neurologic/ocular re-emergence can occur, though many cats remain well. Return of fever, weight loss, fluid, eye change, imbalance, or seizures needs prompt reassessment.

Can I buy GS-441524 online?

Do not rely on unidentified online products. Legal access and quality differ by country. In the US, a specific FDA enforcement-discretion pathway applies to patient-specific veterinary compounding, but compounded products remain unapproved [6]. Work through a veterinarian.

Bottom Line

FIP is a systemic inflammatory disease associated with feline coronavirus, not the inevitable result of a positive coronavirus test. It can produce effusion, organ lesions, eye disease, neurologic disease, or mixed signs. Diagnosis is built from the whole case and the best available sample; serum antibody and fecal PCR results cannot diagnose FIP by themselves.

The outlook has changed profoundly. GS-441524 and related antiviral strategies allow many cats to achieve sustained remission, and current ABCD guidance calls FIP treatable and frequently curable [5]. Severe early disease, diagnostic uncertainty, formulation quality, access, and relapse remain real. Treatment success statistics should create informed hope, not certainty.

Seek veterinary care quickly, especially for breathing difficulty, neurologic signs, collapse, rapid abdominal enlargement, or inability to eat. Use a veterinarian-prescribed legal supply, follow the monitoring plan, and never alter dose or duration from social media. Fast, evidence-based, compassionate care now gives cats with FIP a chance that did not exist a decade ago.

References

1. Tasker S, et al. Feline infectious peritonitis: European Advisory Board on Cat Diseases guidelines. Viruses. 2023;15:1847. PMID and free full text.
2. Thayer V, et al. 2022 AAFP/EveryCat Feline Infectious Peritonitis Diagnosis Guidelines. J Feline Med Surg. 2022;24:905–933. Free full text.
3. Feline Veterinary Medical Association. FIP Guideline Brief: clinical presentations and diagnostic approach. Accessed July 15, 2026.
4. Felten S, Hartmann K. Diagnosis of feline infectious peritonitis: a review of the current literature. Viruses. 2019;11:1068. PMID: 31731711.
5. Tasker S, et al. Update on treatment of feline infectious peritonitis: European Advisory Board on Cat Diseases guidelines. Viruses. 2026. PMID: 42043241; free full text.
6. US Food and Drug Administration. FDA announces position on use of compounded GS-441524 to treat FIP. May 10, 2024.
7. Han H, et al. Legal treatment of feline infectious peritonitis in the Netherlands. J Feline Med Surg. 2025. PMID: 41339255.
8. de Witt Curtius C, et al. Navigating neurological re-emergence in feline infectious peritonitis: challenges and insights from GS-441524 and remdesivir treatment. JFMS Open Rep. 2025. PMID: 40980462.
9. Coggins SJ, et al. Outcomes of treatment of cats with feline infectious peritonitis using parenterally administered remdesivir, with or without transition to orally administered GS-441524. J Vet Intern Med. 2023;37:1772–1783. PMID: 37439383.
10. Brostoff T, et al. Treatment of non-effusive feline infectious peritonitis using oral remdesivir or GS-441524: a randomized, double-blind, non-inferiority trial. J Feline Med Surg. 2026;28. PMID: 41781382; free full text.
11. Feline Veterinary Medical Association. 2025 FIP Update Guide: an update on treatment using antiviral drugs. Updated July 2025.
12. European Advisory Board on Cat Diseases. FIP guideline, updated April 26, 2025.